Laboratoire Aguettant

What Laboratoire Aguettant does

Laboratoire Aguettant is a privately held, family-owned French pharmaceutical manufacturer founded in 1903 and headquartered in Lyon, France, structured as a SAS (Société par Actions Simplifiée) with €12,697,000 in share capital. The company develops, manufactures, and commercializes injectable pharmaceutical specialties and medical devices targeted at hospital use, organized around four therapeutic pillars: emergency medicine and resuscitation, anesthesia, neurology (including Parkinson's disease treatments such as Apokinon® and Lecigimon®), and micronutrition/trace-element perfusion solutions. Its portfolio spans 71 SKUs including pre-filled syringes (adrenaline, atropine, rocuronium, ephedrine, sufentanil adjacents), ampoules under the Proamp® brand, polyolefin perfusion bags (glucose, Ringer lactate, polyionic solutions), the secured Chemo Sure chemotherapy perfusion device, Versol® irrigation solutions, diagnostic ELISA kits under the eZYDIAG® brand (anthrax, ricin), and sublingual analgesics such as DZUVEO®.

Production is anchored by two ISO 13485 (GMED) certified sites in France employing 547 people, supported by a 69-person logistics platform in Saint-Fons; commercial reach is delivered via wholly-owned subsidiaries in Germany, Belgium, Spain, Italy, the Netherlands, the United Kingdom, and Asia Pacific, plus a wholesaler-distributor network in France. The company holds the ANSM pharmaceutical establishment authorization (M10/12, 25 January 2010) authorizing medicinal-product manufacture in France. Operations, scientific information, and pharmacovigilance are staffed through dedicated departments with publicly listed contact channels.

Commercial activity is sales-led, selling primarily to hospitals and healthcare institutions in France via a Customer Service department processing direct orders subject to a €200 minimum order value (with administrative fees for orders below the threshold), alongside wholesaler-distributor channels and direct subsidiary sales abroad. Pricing follows a tariff-grid model communicated per customer category under Article L.441-1 of the French Commercial Code. Revenue and ARR are not publicly disclosed; no funding rounds, M&A, or external investors are disclosed in the source material.

Name

Laboratoire Aguettant

Legal name

Laboratoire AGUETTANT

Website

https://aguettant.fr

Company type

Private

Founded year

1903

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Laboratoire Aguettant is a Lyon-based, family-owned French pharmaceutical manufacturer founded in 1903 that develops, produces, and commercializes injectable pharmaceutical specialties and medical devices for hospitals across emergency, anesthesia, neurology, and micronutrition therapy areas, distributing via subsidiaries in seven countries.

Ownership category

akta.pro rank

Product category

Hospital Injectable Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Surgical Appliance and Supplies Manufacturing (339113), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Injectable pharmaceuticals
• Pre-filled syringes
• Hospital medications
• Perfusion solutions
• Pharmaceutical manufacturing

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of injectable pharmaceutical specialties including emergency medications, anesthesia products, neurology treatments, solutions, pre-filled syringes, medical devices, and micronutrition products to hospitals and healthcare facilities

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Laboratoire Aguettant develops, manufactures, and commercializes innovative injectable pharmaceutical products and medical devices for hospital use. Its portfolio spans emergency/resuscitation medications, anesthesia, neurology, pain management, micronutrition, perfusion solutions, pre-filled syringes, diagnostic kits, and selected medical devices (e.g., Chemo Sure, Versol). All products are sold exclusively to healthcare professionals.

Product overview

Laboratoire Aguettant is a French pharmaceutical laboratory that develops, manufactures, and commercializes innovative injectable pharmaceutical products and medical devices for hospital use. The company's portfolio includes emergency and resuscitation medications, anesthesia products, neurology treatments (including Parkinson's disease), and various perfusion solutions. Their product range consists of pre-filled syringes, ampoules, perfusion bags, sterile solutions, medical devices (including the Chemo Sure secured perfusion system and Versol® irrigation solutions), diagnostic kits (eZYDIAG® for anthrax and ricin), and micronutrition products. The company operates certified production facilities and distributes through subsidiaries across Europe (Germany, Belgium, Spain, Italy, Netherlands, UK) and Asia-Pacific.

Differentiator

Problem solved

Functional benefit

Brands

• eZYDIAG: Diagnostic kits including KIT ANTHRAX eZYDIAG and KIT RICINE eZYDIAG for detection purposes

Products and services

• Pre-filled syringes (Adrenaline, Atropine, Ephedrine, Phenylephrine, Suxamethonium, Rocuronium, Lidocaine) Ready-to-use pre-filled syringes delivering emergency and anesthesia drugs (adrenaline, atropine, ephedrine, phenylephrine, suxamethonium, rocuronium, lidocaine) to hospitals, emergency rooms, and anesthesia teams for rapid administration in critical and perioperative care.
• Perfusion solutions (Glucose 5%/10%/30%, Ringer Lactate, Ringer, Polyionique, Sodium Chloride, Sodium Bicarbonate, Water for Injection) Large-volume sterile intravenous perfusion solutions in flexible bags for fluid and electrolyte replacement, hydration, and dilution of compatible medications, supplied to hospital pharmacies and clinical wards.
• Proamp ampoules Single-dose plastic ampoules of injectable drugs used in hospital and clinical settings for accurate dosing and aseptic handling during drug preparation and administration.
• Neurology products (Apokinon, Lecigimon, Sodium Valproate) Injectable specialty neurology treatments (apomorphine for Parkinson's disease, levodopa-carbidopa-entacapone intestinal gel via pump, sodium valproate) targeted at hospital neurologists, movement disorder specialists, and neurology centers.
• Micronutrition products (Junimin, Nutryelt, Phocytan) Concentrated injectable trace element and micronutrient formulations (pediatric and adult: Junimin, Nutryelt; Phocytan phosphate) used in hospital parenteral nutrition protocols for patients unable to feed enterally.
• Pain management injectables (DZUevo, Ketoprofen, Paracetamol) Injectable analgesics and NSAIDs (diclofenac, ketoprofen, paracetamol) supplied to hospitals and post-operative care units for the management of acute and post-operative pain.
• Anesthetics (Lidocaine-Prilocaine, Droperidol) Injectable anesthetic and adjunct products (eutectic lidocaine-prilocaine, droperidol) used by hospital anesthetists and surgical teams for local/topical anesthesia and procedural sedation.
• Medical devices (Chemo Sure, Versol, Miniversol) Medical devices including Chemo Sure (closed-system drug transfer device for safe handling of hazardous injectable cytotoxics) and Versol/Miniversol (sterile solution containers/bags) used by hospital pharmacy and oncology compounding services.
• Diagnostic kit Kit Anthrax eZYDIAG Rapid immunochromatographic diagnostic kit for the detection of Bacillus anthracis, intended for laboratory, defense, and public-health use in suspected anthrax exposure events.
• Diagnostic kit Kit Ricine eZYDIAG Rapid immunochromatographic diagnostic kit for the detection of ricin toxin, intended for laboratory, defense, and public-health use in suspected biothreat events.
• Sodium bicarbonate 1.4% mouthwash solution Sterile 1.4% sodium bicarbonate mouthwash solution for oral hygiene and mucositis care in hospital settings, particularly for oncology and intensive-care patients.

Quantifiable outcome

• Over 20 employees with disability recognition (RQTH) or partial permanent disability

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hikma Pharmaceuticals: Specialty pharmaceutical company with a significant hospital injectables franchise across Europe, the Middle East, and the US. Comparable on injectable hospital pharmaceuticals, with overlapping generic injectable and specialty injectable therapeutic coverage.
• Centre Spécialités Pharmaceutiques (CSP): French specialty pharmaceutical company focused on injectable and sterile pharmaceutical products for hospitals and emergency care. Closely comparable as a France-based specialty injectable peer with overlapping emergency, anesthesia, and resuscitation product categories.
• Fresenius Kabi: Global specialty pharma company focused on injectable pharmaceuticals, infusion therapies, and clinical nutrition for hospitals. Overlaps directly with Aguettant on injectable hospital medications, anesthesia, and parenteral nutrition/micronutrition product lines.
• Sintetica: Swiss specialty pharmaceutical company focused on injectable anesthetics, analgesics, and CNS therapies for hospital use. Closely comparable to Aguettant on injectable anesthesia, neurology, and pre-filled syringe formats targeting European hospitals.

Broad incumbents

• Sandoz: Global generics and biosimilars leader (Novartis division) with a major hospital injectable portfolio including pre-filled syringes, sterile solutions, and anesthesia products. Comparable as a broad incumbent competing for the same hospital injectable tenders as Aguettant.
• B. Braun: German-based global medical and pharmaceutical company with one of the world's largest sterile injectable, infusion, and IV solution portfolios serving hospitals. Directly comparable to Aguettant on hospital injectables, perfusion solutions, and anesthesia products, though at far greater scale.
• Baxter International: US-headquartered global hospital products company with a broad sterile injectable, IV solution, and medical device portfolio. A direct comparator on hospital injectables, perfusion bags, and sterile irrigation products similar to Aguettant's Versol and Polyionique lines.

Emerging players

• Baxter (Vantive) / Vantive Kidney Care: Emerging specialty player carved from Baxter's kidney-care business with a portfolio of sterile solutions and injectable therapies for hospital and chronic care settings. Comparable on sterile irrigation, perfusion solutions, and injectable products for hospitals.

Regional players

• STEROP Pharmacobel: Belgian specialty pharmaceutical company specializing in injectable ampoules and pre-filled syringes for hospitals across Benelux and Europe. Directly comparable on ampoule and pre-filled syringe injectable formats and on European specialty injectable positioning.
• Ethypharm: French specialty pharmaceutical company focused on injectable and CNS treatments for hospital use. Comparable as a France-headquartered specialty pharma peer overlapping on injectable neurology and pain management formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/laboaguettant
• YouTubeyoutube.com/channel/UC3EiHHOFntmQmKA9CTcLNVQ
• LinkedInlinkedin.com/company/71569695

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire Aguettant